Old Web
English
Sign In
Acemap
>
authorDetail
>
Chia C. Portera
Chia C. Portera
Pennsylvania State University
Medicine
FOLFIRI
Colorectal cancer
Internal medicine
Dulanermin
3
Papers
38
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Phase Ib study of dulanermin combined with FOLFIRI (with or without bevacizumab [BV]) in previously treated patients (Pts) with metastatic colorectal cancer (mCRC).
2017
Journal of Clinical Oncology
Saifuddin Kasubhai
Johanna C. Bendell
Mark Kozloff
Amy V. Kapp
Avi Ashkenazi
Stephanie Royer-Joo
Chia C. Portera
Show All
Source
Cite
Save
Citations (14)
Phase I study of safety and pharmacokinetics (PK) of GDC-0917, an antagonist of inhibitor of apoptosis (IAP) proteins in patients (Pts) with refractory solid tumors or lymphoma.
2013
Journal of Clinical Oncology
Anthony W. Tolcher
Kyriakos P. Papadopoulos
Amita Patnaik
Wayne J. Fairbrother
Harvey Wong
Nageshwar Budha
Walter C. Darbonne
Franklin Peale
Michael Mamounas
Stephanie Royer-Joo
Ron Yu
Chia C. Portera
Johanna C. Bendell
Howard A. Burris
Jeffrey R. Infante
Show All
Source
Cite
Save
Citations (14)
FOLFIRI plus dulanermin (rhApo2L/TRAIL) in a patient with BRAF-mutant metastatic colon cancer
2013
Cancer Biology & Therapy
Bora Lim
Angelique Scicchitano
Cheryl Beachler
Niraj J. Gusani
Nabeel Sarwani
Zhaohai Yang
Kevin F. Staveley-O'Carroll
Avi Ashkenazi
Chia C. Portera
Wafik S. El-Deiry
Show All
Source
Cite
Save
Citations (10)
1